Cian Healthcare Peer Comparison

BSE: 542678

₹13.39

₹0.63 (4.94%)

As on 04-Sep-2026 11:04IST

Market cap

₹32 Cr

Revenue (TTM)

₹31 Cr

P/E Ratio

--

P/B Ratio

2.1

Div. Yield

0 %

Edit

	Cian Healthcare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Market cap (₹ Cr)	32	38,731	21,147	21,290	18,155
Revenue (₹ Cr)	31	4,148	2,570	2,287	3,230
Net Profit (₹ Cr)	-25.98	709.47	735.15	678.07	666.92
Net Margin (%)	-83.62	16.85	26.88	28.10	20.60
RoE (%)	-93.54	19.11	19.16	19.73	18.75
Price to Earnings	--	54.59	28.77	32.00	28.20
Price-To-Book	2.09	9.31	4.80	5.65	4.50

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Cian Healthcare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Operating Revenue	30.80	3,917.99	2,281.35	1,937.47	2,893.64
Total Income	31.07	3,957.03	2,453.60	2,033.90	2,912.00
Total Expenditure	37.38	2,886.87	1,541.03	1,290.54	1,876.44
EBITDA	-6.58	1,031.12	740.32	646.93	1,017.20
Depreciation	4.39	171.04	60.79	65.96	315.46
EBIT	-10.97	860.08	679.53	580.97	701.74
Interest	3.04	11.73	8.50	0.61	231.29
Other Income	0.27	39.04	172.25	96.43	18.36
Exceptional Items	-12.25	--	172.81	--	--
Profit before Tax	-26.00	887.39	1,016.09	676.78	488.87
Provision for Tax	-0.02	227.81	248.49	135.69	114.20
Profit after Tax	-25.98	659.58	767.60	541.09	374.67

Liabilities (₹ Cr)

	Cian Healthcare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Shareholder's Funds	32.36	3,433.32	4,217.41	2,850.49	2,854.36
Minority Interest	--	--	--	35.90	417.40
Non-Current Liabilities	9.21	443.23	54.89	13.24	2,100.97
Current Liabilities	114.49	1,156.93	569.51	305.99	1,492.79
Total Liabilities	156.06	5,033.48	4,911.11	3,207.85	6,865.52

Assets (₹ Cr)

	Cian Healthcare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Non-Current Assets	68.09	2,586.15	1,328.96	1,071.67	5,531.13
Current Assets	70.84	2,447.33	3,512.85	2,133.95	1,334.39
Total Assets	156.06	5,033.48	4,911.11	3,207.85	6,865.52
Total Debt*	54.99	13.80	2.50	0.55	2,421.66
Net Current Assets	-43.65	1,290.40	2,943.34	1,827.96	-158.40
Contingent Liabilities	--	131.94	363.79	0.64	51.96

Cashflow (₹ Cr)

	Cian Healthcare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Cash From Operating Activities	20.75	902.45	659.75	432.37	1,065.01
Cash Flow from Investing Activities	-0.25	-295.90	-71.34	-334.73	-79.97
Cash from Financing Activities	-3.92	-579.67	-205.34	-38.32	-881.32
Net Cash Inflow / Outflow	16.58	26.88	383.07	59.32	103.72

Ratios

Profitability Ratios

	Cian Healthcare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
ROCE (%)	-27.62	26.73	26.21	26.22	13.59
ROE (%)	-93.54	21.81	19.65	21.72	13.81
ROA (%)	-16.38	13.58	17.03	18.37	5.48
EBIT Margin (%)	-20.50	27.31	40.00	38.37	35.79
Net Margin (%)	-83.62	16.67	31.28	26.60	12.87
Cash Profit Margin (%)	-70.09	20.46	34.70	31.33	23.21

Growth Ratios

	Cian Healthcare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Revenue Growth (%)	-50.08	12.45	4.02	14.37	44.02
EBIT Growth (%)	-154.85	14.56	11.86	20.21	48.22
Net Profit Growth (%)	-3,161.22	19.35	39.23	17.27	-5.65
EPS Growth (%)	-3,161.18	18.98	39.23	17.25	-10.39
Book Value Growth (%)	-62.23	17.31	17.30	23.77	10.19

Valuation Ratios

	Cian Healthcare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Price / Earnings	0.00	38.29	23.86	28.38	54.83
Price / Book Value	0.57	7.73	4.34	5.52	6.78
Dividend Yield (%)	0.00	0.96	4.12	0.30	0.52
EV/EBITDA	-7.26	23.49	17.01	19.78	20.75
Market Cap (₹ Cr)	8.62	25,253.79	18,318.10	15,219.80	19,292.77

Solvency Ratios

	Cian Healthcare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Debt to Equity	3.61	0.00	0.00	0.00	0.85
Short term debt to equity ratio	0.88	0.00	0.00	0.00	0.14
Current Ratio	0.62	2.12	6.17	6.97	0.89
Quick Ratio	0.39	1.66	5.33	5.88	0.67
Interest Coverage	-7.56	76.66	120.54	1,110.48	3.11

Operating Efficiency Ratios

	Cian Healthcare	JB Chemicals	Pfizer	Caplin Point Lab	Eris Lifesciences
Debtors to sales (%)	56.47	20.81	8.46	32.65	15.85
Asset Turnover	0.19	0.84	0.53	0.66	0.43
Receivable days	224.43	67.54	29.10	110.70	54.06
Inventory Days	397.03	46.37	69.53	65.86	32.16
Payable days	566.18	106.33	76.77	105.88	140.91
Cash Conversion Cycle	55.28	7.58	21.86	70.68	-54.69